Author:
Mota Augusto,Deisseroth Albert
Reference81 articles.
1. The combination of chemotherapy with IL-2 and alFN is more active than chemotherapy or immunotherapy alone in patients with metastatic melanoma: A meta-analysis of 7711 patients with metastatic melanoma;Allen;Proc Am Soc Clin Oncol,1997
2. Subcutaneous interleukin-2 and interferon-alpha therapy associated with cisplatin monochemotherapy in the treatment of metastatic melanoma;Andres;Eur J Dermatol,1998
3. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993;Atkins;J Clin Oncol,1999
4. The out-patient use of recombinant human interleukin-2 and interferon alfa-2b in advanced malignancies;Atzpodien;Eur J Cancer,1991
5. Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha-2;Atzpodien;Tumour Biol,1993
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献